TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells.
Landolina N, Ricci B, Veneziani I, Alicata C, Mariotti FR, Pelosi A, Quatrini L, Mortari EP, Carsetti R, Vacca P, Tumino N, Azzarone B, Moretta L, Maggi E.
Landolina N, et al. Among authors: alicata c.
Front Immunol. 2024 May 31;15:1368946. doi: 10.3389/fimmu.2024.1368946. eCollection 2024.
Front Immunol. 2024.
PMID: 38881905
Free PMC article.